Skip to main content
. 2023 Jun 1;30(7):103698. doi: 10.1016/j.sjbs.2023.103698

Table 2.

Molecular docking scores of natural and FDA-approved PARP-1 inhibitors.

Sl No. Drugs Glide Score Glide EvdW Glide e Model Glide ecoul G rotatable bonds XP Hbond
1 Ellagic acid −11.024 −37.147 −81.446 −17.073 4 −4.443
2 Naringin −10.793 −40.984 −80.325 −18.185 14 −1.859
3 Icogenin −10.232 −36.886 −74.941 −24.513 23 −5.822
4 EGCG −10.072 −49.769 −91.458 −17.546 12 −3.904
5 Silymarin −10.051 −48.812 −85.121 −9.151 9 −2.683
6 Macranthoside B −10.048 −42.519 −47.046 −10.721 25 −2.673
7 Curcumin −8.839 −45.529 −80.529 −9.703 10 −3.32
8 Quercetin −8.819 −31.717 −63.237 −14.093 6 −2.488
9 Poncirin −8.789 −40.697 −74.371 −15.784 14 −2.4
10 Baicalein −8.762 −34.268 −61.18 −13.675 4 −2.835
Molecular docking scores of FDA-approved PARP-1 inhibitors
1 Olaparib −12.840 −53.005 −105.69 −13.940 6 −2.800
2 Talazoparib −10.545 −40.674 −64.57 −8.531 2 −1.761
3 Niraparib −7.911 −37.699 −76.205 −12.253 3 −1.89
4 Rucaparib −6.678 −41.864 −60.681 −1.309 3 −0.554